BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 33769465)

  • 1. One-Step Multiplexed Droplet Digital Polymerase Chain Reaction for Quantification of p190 BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia.
    Martinez RJ; Kang Q; Nennig D; Bailey NG; Brown NA; Betz BL; Tewari M; Thyagarajan B; Bachanova V; Mroz P
    Arch Pathol Lab Med; 2022 Jan; 146(1):92-100. PubMed ID: 33769465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia.
    Franke GN; Maier J; Wildenberger K; Cross M; Giles FJ; Müller MC; Hochhaus A; Niederwieser D; Lange T
    J Mol Diagn; 2020 Jan; 22(1):81-89. PubMed ID: 31669230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients.
    Cortés AA; Olmedillas S; Serrano-López J; Lainez-González D; Castaño T; Iñiguez R; Lopez-Lorenzo JL; García A; Atance M; Sánchez RNS; Lopez CB; Arranz MG; Sillero PL; Alonso-Dominguez JM
    Mol Diagn Ther; 2020 Oct; 24(5):593-600. PubMed ID: 32875515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M; Whale AS; Akiki S; Piechocki K; Torrado C; Myint T; Cowen S; Griffiths M; Reid AG; Apperley J; White H; Huggett JF; Foroni L
    Clin Chem; 2017 Feb; 63(2):525-531. PubMed ID: 27979961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
    Kjaer L; Skov V; Andersen MT; Aggerholm A; Clair P; Gniot M; Soeby K; Udby L; Dorff MH; Hasselbalch H; Pallisgaard N
    Eur J Haematol; 2019 Jul; 103(1):26-34. PubMed ID: 30985947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation.
    Kottwitz D; El Hadi H; El Amrani M; Cabezas S; Dehbi H; Nadifi S; Quessar A; Colomer D; Moumen A; Sefrioui EL
    Int J Hematol; 2015 Sep; 102(3):335-41. PubMed ID: 26243622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR.
    Jennings LJ; George D; Czech J; Yu M; Joseph L
    J Mol Diagn; 2014 Mar; 16(2):174-9. PubMed ID: 24389534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droplet digital polymerase chain reaction improves the detection of BCR-ABL1 kinase domain mutation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Wan L; Ma J; Gong X; Li Q; Wang Y; Wei H; Wang J; Xiao Z; Mi Y
    Int J Lab Hematol; 2023 Aug; 45(4):528-532. PubMed ID: 36990968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
    Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
    Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.
    Salmon M; White HE; Zizkova H; Gottschalk A; Motlova E; Cerveira N; Colomer D; Coriu D; Franke GN; Gottardi E; Izzo B; Jurcek T; Lion T; Schäfer V; Venturi C; Vigneri P; Zawada M; Zuna J; Hovorkova L; Koblihova J; Klamova H; Markova MS; Srbova D; Benesova A; Polivkova V; Zackova D; Mayer J; Roeder I; Glauche I; Ernst T; Hochhaus A; Polakova KM; Cross NCP
    Leukemia; 2022 Jul; 36(7):1879-1886. PubMed ID: 35676453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia.
    Shelton DN; Bhagavatula P; Sepulveda N; Beppu L; Gandhi S; Qin D; Hauenstein S; Radich J
    PLoS One; 2022; 17(3):e0265278. PubMed ID: 35298544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TaqMan RT-PCR assay coupled with capillary electrophoresis for quantification and identification of bcr-abl transcript type.
    Luthra R; Sanchez-Vega B; Medeiros LJ
    Mod Pathol; 2004 Jan; 17(1):96-103. PubMed ID: 14657955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia.
    Ansuinelli M; Della Starza I; Lauretti A; Elia L; Siravo V; Messina M; De Novi LA; Taherinasab A; Canichella M; Guarini A; Foà R; Chiaretti S
    Hematol Oncol; 2021 Dec; 39(5):680-686. PubMed ID: 34402088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Digital Droplet PCR for BCR-ABL.
    Maier J; Lange T; Cross M; Wildenberger K; Niederwieser D; Franke GN
    J Mol Diagn; 2019 Jan; 21(1):27-37. PubMed ID: 30347270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay.
    Chung HJ; Hur M; Yoon S; Hwang K; Lim HS; Kim H; Moon HW; Yun YM
    Ann Lab Med; 2020 Jan; 40(1):72-75. PubMed ID: 31432643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response.
    Iacobucci I; Lonetti A; Venturi C; Ferrari A; Papayannidis C; Ottaviani E; Abbenante MC; Paolini S; Bresciani P; Potenza L; Parisi S; Cattina F; Soverini S; Russo D; Luppi M; Martinelli G
    Leuk Res; 2014 May; 38(5):581-5. PubMed ID: 24630366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
    Ruiz MS; Sánchez MB; Vera Contreras YM; Agrielo E; Alonso M; Altuna ME; Anchordoqui MS; Asinari M; Bonetto ME; Camargo M; Giere I; González J; Granda Alacote AC; Guerra J; Gutiérrez M; Maldonado C; Makiya R; Manrique G; Monaco ME; Rozo JC; Santamaría C; Seravalle A; Zea O; Zubillaga MN; Mordoh J; Larripa I; Bianchini M
    Clin Chem Lab Med; 2020 Nov; 58(12):2025-2035. PubMed ID: 32374276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single monochrome real-time RT-PCR assay for identification, quantification, and breakpoint cluster region determination of t(9;22) transcripts.
    Gutiérrez MI; Timson G; Siraj AK; Bu R; Barbhaya S; Banavali S; Bhatia K
    J Mol Diagn; 2005 Feb; 7(1):40-7. PubMed ID: 15681473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
    Kurita D; Hatta Y; Hojo A; Kura Y; Sawada U; Kanda Y; Takei M
    Cancer Genet; 2016 Apr; 209(4):161-5. PubMed ID: 26854094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of tyrosine kinase inhibitors based on
    Kim Y; Kim S; Lee JM; Ahn A; Yoo JW; Lee JW; Cho B; Chung NG; Kim Y; Kim M
    Front Pediatr; 2022; 10():928136. PubMed ID: 35967571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.